concept

ALZHEIMER'S DISEASE PROGRESSION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALZHEIMER'S DISEASE PROGRESSION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

27Connections

0Hypotheses

2Analyses

0Outgoing

27Incoming

0Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	ALZHEIMER'S DISEASE PROGRESSION

Pathway Diagram

graph TD
    ALZHEIMER_S_DISEASE_PROGRESSIO["ALZHEIMER'S DISEASE PROGRESSION"]
    TET2_Mutant_Myeloid_Cells["TET2-Mutant Myeloid Cells"] -->|"inhibits"| ALZHEIMER_S_DISEASE_PROGRESSIO
    Enhanced_Phagocytosis["Enhanced Phagocytosis"] -->|"inhibits"| ALZHEIMER_S_DISEASE_PROGRESSIO
    Cerebrospinal_Fluid_Biomarkers["Cerebrospinal Fluid Biomarkers"] -.biomarker for.-> ALZHEIMER_S_DISEASE_PROGRESSIO
    Metabolic_Dysfunction["Metabolic Dysfunction"] -->|"contributes to"| ALZHEIMER_S_DISEASE_PROGRESSIO
    Gut_Brain_Axis["Gut-Brain Axis"] -->|"modulates"| ALZHEIMER_S_DISEASE_PROGRESSIO
    CNS_Infiltration["CNS Infiltration"] -->|"mediates"| ALZHEIMER_S_DISEASE_PROGRESSIO
    Cortical_Astrocytes["Cortical Astrocytes"] -->|"modulates"| ALZHEIMER_S_DISEASE_PROGRESSIO

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (27)

Source	Relation	Type	Str
TET2-Mutant Myeloid Cells	inhibits	cell_type	0.95
Enhanced Phagocytosis	inhibits	process	0.90
39402379	characterized by	paper	0.90
Metabolic Dysfunction	contributes_to	disease	0.90
Cerebrospinal Fluid Biomarkers	biomarker_for	biomarker	0.90
Gut-Brain Axis	modulates	pathway	0.90
Gut-Brain Axis	modulates	pathway	0.88
CNS Infiltration	mediates	process	0.88
Cortical Astrocytes	modulates	cell_type	0.87
Plasma GFAP	risk_factor_for	biomarker	0.87
AMYLOID BETA	associated_with	protein	0.85
APOE4	risk_factor_for	gene	0.85
Gut Microbiota Alterations	contributes_to	biomarker	0.85
YKL-40	risk_factor_for	protein	0.85
Blood-Brain Barrier Function Preservation	protects_against	process	0.85
Neuromelanin Loss	contributes_to	phenotype	0.85
CNS Infiltration	modulates	process	0.85
Phagocytosis	involved_in	process	0.85
Disease-Associated Microglia	modulates	cell_type	0.85
Gut Microbiota Dysbiosis	biomarker_for	biomarker	0.82
DAM Activation	modulates	process	0.80
DAM Activation	inhibits	process	0.80
NREM Sleep Reduction	contributes_to	phenotype	0.80
Amyloid beta clearance	modulates	process	0.75
neurofilament light chain	biomarker_for	biomarker	0.70
anti-amyloid monotherapy	modulates	drug	0.70
inflammatory cytokines	associates_with	process	0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.387

Why have numerous phase 3 clinical trials failed despite advances in understandi

neurodegeneration | 2026-04-12 | 1 hypotheses Top: 0.566

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

completed · Rounds: 5 · Score: 0.50 · 2026-04-25

Why have numerous phase 3 clinical trials failed despite advances in understandi

closed · Rounds: 5 · Score: 0.67 · 2026-04-12

Related Research

Hypotheses and analyses mentioning ALZHEIMER'S DISEASE PROGRESSION in their description or question text

No additional research found